Professional Reference articles are designed for health professionals to use. They are written by UK doctors and based on research evidence, UK and European Guidelines. You may find the மலக்குடல் இரத்தப்போக்கு - மலத்தில் இரத்தம் (Blood in Faeces) article more useful, or one of our other health articles.
Treatment of almost all medical conditions has been affected by the COVID-19 pandemic. NICE has issued rapid update guidelines in relation to many of these. This guidance is changing frequently. Please visit https://www.nice.org.uk/covid-19 to see if there is temporary guidance issued by NICE in relation to the management of this condition, which may vary from the information given below.
The passage of blood per rectum is a very common symptom. It is often attributed by patients to haemorrhoids and these are a common cause of this symptom. However, there are other causes and it is important to know what the possible causes are and when and how to investigate this symptom further.
The type and amount of the bleeding as well as the age of the patient are important in initial assessment of the bleeding. There are many causes of rectal bleeding and the likely aetiology depends on the age of the patient and the frequency of the underlying diseases in a given population.
Rectal bleeding always warrants further assessment and medical advice. It is essential to make appropriate referrals, ie to the right specialist team and with the correct degree of urgency.
For details on rectal bleeding in children see the separate Rectal Bleeding in Children article.
- Rectal bleeding is a very common symptom. It occurs in adults of all ages.
- The 1-year prevalence in adults is about 10% in the UK. Most of this will not be reported.
- The majority of cases of rectal bleeding are due to benign causes, particularly haemorrhoids and anal fissures. However, there are many other possible causes, some of which are sinister. In particular the cause to be excluded is colorectal cancer.
It is difficult to obtain accurate figures for the relative frequency of the different causes of rectal bleeding. Studies have differing results according to population demographics, patient selection, size of study and other confounding factors. However, it is essential to understand the aetiology, as this shapes the investigations, management and ultimately the likely outcome.
The age of the patient gives a clue to aetiology and as a result forms a part of referral guidelines (see below). Those under the age of 30 presenting with rectal bleeding are more likely to have haemorrhoids, an anal fissure or inflammatory bowel disease. For those over the age of 50, there should be a higher suspicion of colorectal cancer. It should, however, not be forgotten that nearly one third of rectal cancer patients are younger than 55 years of age.
Common causes of rectal bleeding
- Benign anorectal disease:
- Anal fissure.
- Diverticular disease.
- Inflammatory bowel disease:
- Colonic polyps.
- Colorectal or anal cancer.
Less common causes of rectal bleeding
- Infectious gastroenteritis.
- Arteriovenous malformation (angiodysplasia).
- Massive upper gastrointestinal (GI) bleeding.
- Radiation proctitis.
- Ischaemic colitis (mesenteric vascular insufficiency).
- Solitary rectal ulcer.
- Dieulafoy's lesion of small or large bowel.
- Meckel's diverticulum (in adults less often than children).
- Rectal varices.
- GI tract invasion of non-GI tract malignancy.
- Trauma (possible sexual abuse).
- Sexually transmitted infections.
In assessing rectal bleeding it is important to identify important presenting features as these can give clues to the likely aetiology and severity of bleeding. It is, for example, important to assess the amount of bleeding. There are three classifications according to the amount of bleeding:
- Occult bleeding - presenting with anaemia.
- Moderate bleeding - presenting with rectal bleeding (fresh or dark), or melaena in a patient who is haemodynamically stable.
- Massive bleeding - presenting with large amounts of blood passed rectally (may be dark but often fresh).
There may be:
- Shock with systolic blood pressure below systolic 90 mm Hg.
- Initial drop in haematocrit and haemoglobin less than 6 g/dL.
- Requirement for transfusion of two units of blood or more.
- Persistence of bleeding for more than three days.
- Significant re-bleeding within a week.
Massive lower GI bleeding requires urgent admission.
Important details to elicit include:
- The quantity and nature of bleeding:
- Fresh bright red blood usually comes from low down in the GI tract. Examples include fissures and haemorrhoids.
- Bright red blood, however, can also occur with pathology higher in the GI tract.
- Blood mixed in with the stool has usually originated higher in the GI tract.
- The quantity of blood is very difficult to assess from the history but it is important to obtain a description from the patient. Indirect measures of the severity of bleeding are helpful.
- Unexplained weight loss.
- Change in bowel habit (both frequency of defecation and consistency of stool) must be recognised.
- Tenesmus. May be a feature (for example, with fissures).
- Anal symptoms - eg, soreness or pain may occur with fissures, itching with piles.
- Family history of bowel cancer or polyposis.
- Past medical history. Careful documentation with particular reference to causes of bleeding and GI tract pathology. Any history of trauma should not be overlooked.
- Medication history. This may identify causes of bleeding (for example, warfarin and aspirin).
- General features. Look for:
- Pallor or anaemia.
- Cardiovascular signs of shock, including tachycardia and hypotension (including orthostatic hypotension).
- Cachexia or obvious weight loss.
- Abdominal examination. Look for:
- Stool examination or description:
- Examination of stool may be possible, particularly on a home visit if the motion is still available to be seen.
- Blood mixed with stool: the blood is darker and this usually indicates a lesion on the left side of the colon or even transverse colon (often carcinoma or inflammatory bowel disease).
- Shiny black- or plum-coloured stool is often not recognised by the patient as blood (melaena). This indicates bleeding from higher up the GI tract - these patients need admission for investigation (usually upper GI tract endoscopy), either immediately or through an upper GI tract bleeding fast-track service (see the separate Upper Gastrointestinal Bleeding (includes Rockall Score) article).
- Bright red blood suggests a lesion in the rectum or anus. If blood is clearly separate from a stool, it indicates an anal lesion, usually haemorrhoids or a fissure - particularly if there are associated anal symptoms (for example, anal pain or pruritus ani) but, occasionally, other pathology (for example, proctitis or anal carcinoma). This emphasises the need for rectal examination.
- With blood on the surface of the stool the lesion can be anal, but may be a more proximal lesion (for example, polyp or carcinoma in the rectum or descending colon).
- Rectal examination:
- A digital rectal examination is usually appropriate, both to confirm blood in the rectum and to exclude any rectal or pelvic masses.
- If the patient is not to be referred to secondary care for investigation, a digital rectal examination is essential.
- Remember the finding of haemorrhoids or fissures does not necessarily exclude more proximal causes of bleeding.
- Proctoscopy should help identify anorectal sources of bleeding. It cannot be used as a substitute for sigmoidoscopy, however, in ruling out serious pathology .
The investigations chosen will depend on the particular mode of presentation and likely diagnosis. Unnecessary investigation should not delay referral where there is a high suspicion of malignancy. Rectal examination and FBC are worth performing on most patients prior to referral. Further blood tests will be guided by the presentation.
- FBC (and group and save if bleeding is profound or anaemia suspected).
- Ferritin and iron studies if iron-deficiency anaemia is suspected.
- Clotting studies may be appropriate.
- LFTs may be indicated if liver disease is suspected.
- Faecal calprotectin is a useful screen in younger patients suspected of having inflammatory bowel disease, and has a high positive predictive value .
Dr Krishna Vakharia, 12th September 2023
- An abdominal mass, or
- A change in bowel habit, or
- Iron-deficiency anaemia, or
- Aged 40 and over with unexplained weight loss and abdominal pain, or
- Aged under 50 with rectal bleeding and either unexplained abdominal pain or weight loss, or
- Aged 50 and over with unexplained rectal bleeding, abdominal pain or weight loss, or
- Aged 60 and over with anaemia even in the absence of iron deficiency.
- Safety netting processes should be put in place.
- Referral should not be delayed if there is a strong clinical concern of cancer due to unexplained symptoms.
There is no evidence that tumour markers such as carcinoembryonic antigen (CEA) are useful as diagnostic tools in this situation .
Further investigation in secondary care
- Flexible sigmoidoscopy. This is the investigation of choice for younger patients where there is concern about pathology other than haemorrhoids, or those who have persistent bleeding following treatment for haemorrhoids.
- Colonoscopy. This is the definitive investigation where there is a high suspicion of malignancy, or a family history. It allows tissue biopsy and removal. However, it does not have a perfect pick-up rate and is an unpleasant test. Therefore, virtual colonoscopy has been approved as an effective alternative.
- Virtual colonoscopy (computerised tomography (CT) colonography). This method uses CT to examine the prepared, distended colon. Interpretation of the data combines two-dimensional methods with three-dimensional 'endoscopic fly-through' simulations - hence, 'virtual' colonoscopy. It is approved by National Institute for Health and Care Excellence (NICE) and Royal College of Radiologists (RCR) guidelines as a highly sensitive and well-tolerated tool in the diagnosis of colorectal cancer[7, 8] .
Guidance on urgency of referral for one of these investigations is given below. Barium enema is no longer considered to have a role in the investigation of rectal bleeding, due to its poor sensitivity and tolerability.
This will be determined by the eventual diagnosis and the severity of bleeding. It is important to know when to refer.
When to refer
Referral may be:
- Routine - may be appropriate for low-risk and benign conditions.
- Urgent (within two weeks).
- Emergency (immediate) when there is massive bleeding.
Referral of suspected cancer
Refer the following people under a two-week wait suspected cancer pathway for colorectal cancer:
- Those aged ≥40 with unexplained weight loss and abdominal pain.
- Those aged ≥50 with unexplained rectal bleeding.
- Those aged ≥60 with:
- Iron-deficiency anaemia; or
- Change in bowel habit.
- Those whose tests have been positive for occult blood in their faeces - NICE guidelines advise occult blood is tested for in:
- Those aged ≥50 with unexplained abdominal pain or weight loss.
- Those aged <60 with change in bowel habit, or iron-deficiency anaemia.
- Those aged ≥60 with anaemia, whether iron-deficient picture or not.
Consider referring the following people under a two-week wait suspected cancer pathway for colorectal cancer:
- All those with a rectal or abdominal mass.
- Those aged <50 with rectal bleeding along with any of the following:
- Unexplained abdominal pain.
- Unexplained change in bowel habit.
- Unexplained weight loss.
- Unexplained iron-deficiency anaemia.
Consider referring any person with an unexplained anal mass or unexplained anal ulceration under a two-week wait suspected cancer pathway for anal cancer.
Dr Sarah Jarvis, 11th February 2021
In September 2020 and again in January 2021, NICE updated its guidance on suspected cancer recognition and referral . While there is no updated recommendation on the management of rectal bleeding, the guidance does recommend quantitative faecal immunochemical tests to assess for colorectal cancer in adults without rectal bleeding who:
- Are aged 50 and over with unexplained:
- Changes in their bowel habit; or
- Iron-deficiency anaemia.
- Are aged 60 and over and have anaemia even in the absence of iron deficiency.
Assessing acute bleeding
The British Society of Gastroenterology has produced guidance for those assessing cases of acute lower intestinal bleeding in hospital. This may also be useful for those considering referral.
- Patients presenting with lower gastrointestinal bleeding (LGIB) should be stratified as unstable or stable (unstable defined as a shock index >1, the shock index being the ratio between heart rate and systolic blood pressure). Stable bleeds should then be categorised as major or minor, using a risk assessment tool such as the Oakland score (a calculation based on various criteria such as age, haemoglobin level and digital rectal examination findings).
- Patients presenting with a minor self-terminating bleed (such as those with an Oakland score ≤8 points), with no other indications for hospital admission may be discharged for urgent outpatient investigation.
- Patients with a major bleed should be admitted to hospital for colonoscopy on the next available list.
- If a patient is haemodynamically unstable or has a shock index of >1 after initial resuscitation and/or active bleeding is suspected, CT angiography (CTA) should be considered, followed by endoscopic or radiological therapy.
- As LGIB associated with haemodynamic instability may be indicative of an upper gastrointestinal bleeding source, an upper endoscopy should be performed immediately if no source is identified by initial CTA. If the patient stabilises after initial resuscitation, gastroscopy may be the first investigation.
- Where indicated, catheter angiography with a view to embolisation should be performed as soon as possible after a positive CTA to maximise chances of success. In centres with a 24/7 interventional radiology service, this should be available within 60 minutes for haemodynamically unstable patients.
- No patient should proceed to emergency laparotomy unless every effort has been made to localise bleeding by radiological and/or endoscopic modalities, except under exceptional circumstances.
- Red blood cell transfusion may be required.
- If the patient is on antiplatelet/anticoagulant therapy, this may need to be adjusted.
This naturally depends on the cause, as well as other factors such as age and comorbidity.
No individual feature or symptom associated with rectal bleeding is strongly predictive of the eventual cause being diagnosed as colorectal cancer. However, certain associated features do make this cause more likely. These include:
- Weight loss.
- Age over 50.
- Change in bowel habit.
- Iron-deficiency anaemia.
- Blood mixed with stool.
- A strong family history of colorectal cancer .
Further reading and references
Colorectal cancer (management in people aged 18 and over); NICE Guidance (2020, last updated December 2021)
Fok KY, Murugesan JR, Maher R, et al; Management of per rectal bleeding is resource intensive. ANZ J Surg. 2019 Apr89(4):E113-E116. doi: 10.1111/ans.15149. Epub 2019 Mar 18.
Hudspath C, Russell D, Eum K, et al; Finding the Dieulafoy's Lesion: A Case of Recurrent Rectal Bleeding in an Immunosuppressed Patient. Case Rep Gastrointest Med. 2019 Jul 32019:9402968. doi: 10.1155/2019/9402968. eCollection 2019.
Percac-Lima S, Pace LE, Nguyen KH, et al; Diagnostic Evaluation of Patients Presenting to Primary Care with Rectal Bleeding. J Gen Intern Med. 2018 Apr33(4):415-422. doi: 10.1007/s11606-017-4273-x. Epub 2018 Jan 4.
Walsh CJ, Delaney S, Rowlands A; Rectal bleeding in general practice: new guidance on commissioning. Br J Gen Pract. 2018 Nov68(676):514-515. doi: 10.3399/bjgp18X699485.
Royal College of Surgeons; Commissioning Guide for Rectal Bleeding, 2017
Khodadoostan M, Shavakhi A, Padidarnia R, et al; Full colonoscopy in patients under 50 years old with lower gastrointestinal bleeding. J Res Med Sci. 2018 May 3023:45. doi: 10.4103/jrms.JRMS_531_17. eCollection 2018.
Lue A, Hijos G, Sostres C, et al; The combination of quantitative faecal occult blood test and faecal calprotectin is a cost-effective strategy to avoid colonoscopies in symptomatic patients without relevant pathology. Therap Adv Gastroenterol. 2020 May 1813:1756284820920786. doi: 10.1177/1756284820920786. eCollection 2020.
Suspected cancer: recognition and referral; NICE guideline (2015 - last updated October 2023)
Burling D, East JE, Taylor SA; Investigating rectal bleeding. BMJ. 2007 Dec 15335(7632):1260-2.
Computed tomographic colonography (virtual colonoscopy); NICE Interventional Procedures Guidance, June 2005
Guideline on the use of CT colonography for suspected colorectal cancer; British Society of Gastrointestinal and Abdominal Radiology (BSGAR) and the Royal College of Radiologists, 2014
Oakland K, Chadwick G, East JE, et al; Diagnosis and management of acute lower gastrointestinal bleeding: guidelines from the British Society of Gastroenterology. Gut. 2019 May68(5):776-789. doi: 10.1136/gutjnl-2018-317807. Epub 2019 Feb 12.
Astin M, Griffin T, Neal RD, et al; The diagnostic value of symptoms for colorectal cancer in primary care: a systematic review. Br J Gen Pract. 2011 May61(586):e231-43. doi: 10.3399/bjgp11X572427.